- Home
- Publications
- Publication Search
- Publication Details
Title
Red Yeast Rice for the Treatment of Dyslipidemia
Authors
Keywords
Red yeast rice, Monacolin K, Lovastatin, Hypercholesterolemia, Dyslipidemia, Statin-associated myalgia (SAM), HMG CoA reductase inhibitor, Xuezhikang, Mevacor
Journal
Current Atherosclerosis Reports
Volume 17, Issue 4, Pages -
Publisher
Springer Nature
Online
2015-03-02
DOI
10.1007/s11883-015-0495-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effects of Xuezhikang in patients with dyslipidemia: A multicenter, randomized, placebo-controlled study
- (2014) Patrick M. Moriarty et al. Journal of Clinical Lipidology
- A Meta-Analysis of Red Yeast Rice: An Effective and Relatively Safe Alternative Approach for Dyslipidemia
- (2014) Yinhua Li et al. PLoS One
- Phytosterols, red yeast rice, and lifestyle changes instead of statins: A randomized, double-blinded, placebo-controlled trial
- (2013) David J. Becker et al. AMERICAN HEART JOURNAL
- Red Yeast Rice for Dyslipidemia in Statin-Intolerant Patients
- (2013) David J. Becker ANNALS OF INTERNAL MEDICINE
- Red yeast rice lowers cholesterol in physicians - a double blind, placebo controlled randomized trial
- (2013) Veronique Verhoeven et al. BMC Complementary and Alternative Medicine
- Improved dissolution rate and oral bioavailability of lovastatin in red yeast rice products
- (2013) Chia-Hao Chen et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- The effect of red yeast rice (Monascus purpureus) in dyslipidemia and other disorders
- (2012) Clinton W. Yang et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Review of red yeast rice content and current Food and Drug Administration oversight
- (2012) Lindsey Childress et al. Journal of Clinical Lipidology
- Is Red Yeast Rice Safe and Effective for Lowering Serum Cholesterol?
- (2011) Eleese Cunningham JOURNAL OF THE AMERICAN DIETETIC ASSOCIATION
- Lipid-Lowering Efficacy of Red Yeast Rice in a Population Intolerant to Statins
- (2010) Carmelo V. Venero et al. AMERICAN JOURNAL OF CARDIOLOGY
- The Role of Red Yeast Rice for the Physician
- (2010) Ram Y. Gordon et al. Current Atherosclerosis Reports
- Role of dietary supplements in lowering low-density lipoprotein cholesterol: A review
- (2010) Prabhjot S. Nijjar et al. Journal of Clinical Lipidology
- Tolerability of Red Yeast Rice (2,400 mg Twice Daily) Versus Pravastatin (20 mg Twice Daily) in Patients With Previous Statin Intolerance
- (2009) Steven C. Halbert et al. AMERICAN JOURNAL OF CARDIOLOGY
- Beneficial Impact of Xuezhikang on Cardiovascular Events and Mortality in Elderly Hypertensive Patients With Previous Myocardial Infarction From the China Coronary Secondary Prevention Study (CCSPS)
- (2009) Jian-Jun Li et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Simvastatin vs Therapeutic Lifestyle Changes and Supplements: Randomized Primary Prevention Trial
- (2009) David J. Becker et al. MAYO CLINIC PROCEEDINGS
- Effect of Xuezhikang, an Extract From Red Yeast Chinese Rice, on Coronary Events in a Chinese Population With Previous Myocardial Infarction
- (2008) Zongliang Lu et al. AMERICAN JOURNAL OF CARDIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started